Retinoic Acid-Containing Liposomes for the Induction of Antigen-Specific Regulatory T Cells as a Treatment for Autoimmune Diseases
The current treatment of autoimmune and chronic inflammatory diseases entails systemic immune suppression, which is associated with increased susceptibility to infections. To restore immune tolerance and reduce systemic side effects, a targeted approach using tolerogenic dendritic cells (tolDCs) is...
Saved in:
Main Authors: | Daniëlle ter Braake (Author), Naomi Benne (Author), Chun Yin Jerry Lau (Author), Enrico Mastrobattista (Author), Femke Broere (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Increased stimulatory capacity of antigen presenting cells at the site of autoimmune inflammation interferes with regulatory T cell function
by: Meerding J, et al.
Published: (2011) -
The role of T cell miRNAs for regulatory T cell induction in islet autoimmunity
by: Martin G. Scherm, et al.
Published: (2019) -
Retinoic acid liposome-hydrogel: preparation, penetration through mouse skin and induction of F9 mouse teratocarcinoma stem cells differentiation
by: Hongmei Xia, et al.
Published: (2015) -
Bovine cumulus-granulosa cells contain biologically active retinoid receptors that can respond to retinoic acid
by: Malayer Jerry, et al.
Published: (2003) -
Formulations of liposomal vaccine containing AdhO36 antigen and β-glucan as immunoadjuvant
by: Hidajah Rachmawati, et al.
Published: (2021)